Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -115.61M | $ -0.98 | 1 | 118.53M |
3/31/2025 | $ -123.33M | $ -1.04 | 1 | 118.38M |
12/31/2024 | $ -122.87M | $ -1.08 | 1 | 113.69M |
9/30/2024 | $ -131.71M | $ -1.12 | 1 | 117.77M |
6/30/2024 | $ -140.57M | $ -1.2 | 1 | 117.47M |
3/31/2024 | $ -136.75M | $ -1.35 | 1 | 101.1M |
12/31/2023 | $ -132.26M | $ -1.34 | 1 | 98.41M |
9/30/2023 | $ -171.01M | $ -1.73 | 1 | 98.57M |
6/30/2023 | $ -187.79M | $ -1.91 | 1 | 98.4M |
3/31/2023 | $ -212.46M | $ -2.17 | 1 | 98.05M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for FATE THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -44.1M ] / (Shares WA [ 86.89M ] * Share Factor [ 1 ])
(=) OCFPS [ $ -0.51 ]
Minimum
Dec 31, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.65 |
median | $ 0.89 |
std | $ 3.42 |